News & Views
DWS Establish Regenerative Medicine Partnership
Feb 22 2012
Don Whitley Scientific Ltd (DWS) has announced a new venture into the tissue engineering and regenerative medicine market having signed an exclusive distributor agreement with Spanish biotechnology company, Ebers Medical Technology, to sell its systems in the UK.
According to industry analysis company Medmarket Diligence*, the largest market for tissue engineered products is the ‘replacement of structurally or physiologically deficient or diseased tissues and organs in humans’. However, the NHS website ‘Give and Let Live’ states that only a third of people who need an organ transplant actually receive one. This doesn’t even include the statistics for those people needing tissue transplantation, a report said.
The agreement with Ebers Medical, which will see DWS introduce the TEB1000 Master Unit tissue processing system into the UK, also includes distribution of the products in Germany and Australia by DWS subsidiary companies, Meintrup-DWS Laborgeräte GmbH and Don Whitley Scientific PTY.
Managing Director of DWS, Paul Walton, commented:
“This is an exciting product for a relatively young but very important market. Our long history of providing solutions to scientists will help us bring this innovation to tissue engineering specialists who are already making a difference in medicine today.”
*Tissue Engineering, Cell Therapy & Transplantation: Products, technologies & Market Opportunities Worldwide, 2009-2018 (Jan 2010)
Digital Edition
International Labmate Buyers' Guide 2024/25
June 2024
Buyers' Guide featuring: Product Listings & Manufacturers Directory Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters - Digital transformatio...
View all digital editions
Events
Jul 07 2024 Dublin, Ireland
Jul 20 2024 Denver, CO, USA
Jul 21 2024 Cape Town, South Africa
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia